Depressive disorders and problematic drinking often co-occur, also among young adults. These co-occurring conditions are associated with various negative health outcomes compared to both conditions alone. Early intervention by...
Drug-related deaths can result in complex emotional turmoil for family members who are going through a grieving process at the same time as often experiencing a level of stigma.
Despite the high frequency of drug-related deaths worldwide...
The Drink Wise, Age Well programme was delivered over five years from 2015 to 2020 in five intervention areas across the UK.
The project had 4 objectives:
Background: Family caregivers contribute to engagement in treatment and adherence, reduced substance misuse and relapse, and increased well-being of recipients with substance use disorder. However, providing care has also been...
ATOMIC is a free, evidence-based, mobile-learning application aimed at clinicians and other practitioners who want to improve their knowledge of the acute and chronic clinical harms of non-medical prescription drug use. ATOMIC is a response...
This report provides a technical review of the current body of knowledge regarding new benzodiazepines that are monitored by the EU Early Warning System.
The aims of this report are to strengthen situational awareness of new...
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these...
The European Commission announces today the first edition of the Horizon Europe info-days, to take place online from 28 June to 9 July 2021.
Horizon Europe is the EU’s key funding programme for research and innovation with a budget of €95...
